{
    "Trade/Device Name(s)": [
        "BD Directigen\u2122 EZ RSV Assay",
        "Directigen\u2122 EZ RSV test"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K101514",
    "Predicate Device Reference 510(k) Number(s)": [
        "K022133"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "GQG"
    ],
    "Summary Letter Date": "May 28, 2010",
    "Summary Letter Received Date": "June 2, 2010",
    "Submission Date": "May 28, 2010",
    "Regulation Number(s)": [
        "21 CFR 866.3480"
    ],
    "Regulation Name(s)": [
        "Respiratory syncytial virus serological reagents"
    ],
    "Analyte Class(es)": [
        "virology",
        "immunology"
    ],
    "Analyte(s)": [
        "Respiratory Syncytial Virus (RSV) antigen"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal wash",
        "Nasopharyngeal aspirate",
        "Nasopharyngeal swab",
        "Nasopharyngeal swab/wash"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Chromatographic immunoassay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for BD Directigen\u2122 EZ RSV assay using a chromatographic immunoassay to detect RSV antigen in nasopharyngeal specimens of neonatal and pediatric patients.",
    "Indications for Use Summary": "Aids in the diagnosis of RSV infections in neonatal and pediatric patients under age 20 from nasopharyngeal specimens, with negative results recommended to be confirmed by cell culture.",
    "fda_folder": "Microbiology"
}